Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
Ardent Health Partners (ARDT) | Barclays/ Citigroup/ J.P. Morgan/ BofA Merrill Lynch/ Credit Suisse/ Goldman Sachs/ RBC Capital Market | $100.00 | n.a. | |||
n.a. (not available) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
None | ||||||
New Terms | ||||||
360 Finance (QFIN) | Goldman Sachs (Asia)/ Citigroup Global Markets | 3.10 | $16.50 | $18.50 | $54.25 | S/O |
Legacy Housing (LEGH) | B. Riley FBR/ Oak Ridge Financial | 3.50 | $10.75 | $12.75 | $41.13 | S/O |
Tencent Music Entertainment Group (TME) | Morgan Stanley/ Goldman Sachs (Asia)/ J.P. Morgan/ Deutsche Bank Securities/ BofA Merrill Lynch | 82.00 | $13.00 | $15.00 | $1,148.00 | S/O |
S/O (Subscribers Only) | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Dec. 3, 2018 | Manager(s) | Offered | Raised | Price | 12/7/18 | Change |
Synthorx (THOR) | Jefferies/ Leerink Partners/ Evercore ISI | 11.91 | $131.04 | $11.00 | $12.61 | 14.64% |
MOGU (MOGU) | Morgan Stanley/ Credit Suisse/ China Renaissance Securities | 4.75 | $66.50 | $14.00 | $13.48 | -3.71% |
Moderna (MRNA) | Morgan Stanley/ Goldman Sachs/ J.P. Morgan | 26.28 | $604.35 | $23.00 | $18.60 | -19.13% |
DiaMedica Therapeutics (DMAC) | Craig-Hallum Capital Group | 4.10 | $16.40 | $4.00 | $3.10 | -22.50% |